Follicle Stimulating Hormone (Fsh)

The FSH Rapid Test is a qualitative, lateral flow immunoassay for the qualitative
detection of human Follicle Stimulating Hormone in urine to evaluate the onset of
menopause in women. The test utilizes a combination of antibodies including a
monoclonal anti-FSH antibody to selectively detect elevated levels of FSH. The assay
is conducted by adding a urine specimen to the specimen well of the test device and
observing the formation of colored lines.
The specimen migrates via capillary action along the membrane to react with the
colored conjugate. FSH present in the specimen binds to the conjugate, forming a
colored antibody-antigen complex. The FSH antibody immobilized in the test zone of
the membrane captures the FSH-Conjugate (antibody + signal reagent) complex in the
test region and the rabbit antibody immobilized in the control zone of the membrane
captures the conjugate in the control region . Two lines are thus visible. If the line in
test line region is same as or darker than the line in the control line region, it indicates
a positive result. If the line in the test line region is lighter than the line in the control
line region; or if there is no line in the test line region, it indicates a negative result.